Replies to post #4198 on Repros Therapeutics, Inc. (RPRX)

[docbanker]

i think you should listen to the last conference call again.

[charmed1]

AKASID....a partnership doesnt really impact the final
outcome of an outright sale....if he strikes a partnership
deal..either the partner or another company would purchase
the NPV of the future cash flows according to the terms of
the partnership....I think its highly likely he plays it
out for androxal as well....so i think what happens is the
buyer of the proellex franchise, also purchases the NPV
cash flows from an androxal licensing deal...which is why
I stated a long time ago that I think we dont get a buyout
deal until after 2010...

Furthurmore, I am thinking that the end game is no longer
a buyout..we may have to play this as shareholders receiving
the licensing cash flows over a much longer time frame...